Cargando…
Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract
Globally, Respiratory Syncytial Virus (RSV) is a leading cause of bronchiolitis and pneumonia in children less than one year of age and in USA alone, between 85,000 and 144,000 infants are hospitalized every year. To date, there is no licensed vaccine. We have evaluated vaccine potential of mammalia...
Autores principales: | Walpita, Pramila, Johns, Lisa M., Tandon, Ravi, Moore, Martin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501727/ https://www.ncbi.nlm.nih.gov/pubmed/26172453 http://dx.doi.org/10.1371/journal.pone.0130755 |
Ejemplares similares
-
Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection
por: Sommer, Constanze, et al.
Publicado: (2011) -
Detection of respiratory syncytial virus & Mycoplasma pneumoniae in paediatric lower respiratory tract infections
por: Kumar, Sanchit, et al.
Publicado: (2019) -
The Burden of Hospitalized Lower Respiratory Tract Infection due to Respiratory Syncytial Virus in Rural Thailand
por: Fry, Alicia M., et al.
Publicado: (2010) -
Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade
por: Aranda, Sofia S., et al.
Publicado: (2019) -
Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children
por: Englund, Janet A, et al.
Publicado: (2023)